article thumbnail

Delivery systems for biologics

European Pharmaceutical Review

1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5

article thumbnail

Paragonix Technologies Receives FDA Clearance for BAROguard™ Donor Lung Preservation System

Legacy MEDSearch

Paragonix Technologies , a leading organ transplant company, received US Food and Drug Administration (“FDA”) clearance for its next-generation donor lung preservation system, BAROguard. Under current clinical practice, donor lungs are preserved and transported in an inflated state from donor to recipient site.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rare Disease Day 2024: Advocating for Awareness and Support

PM360

Given that less than 10% of rare diseases currently have an available treatment approved by the United States Food and Drug Administration (FDA) , advocating for the speedy development of novel drugs and therapies is a crucial step in improving the quality of life for those affected. What is a Rare Disease?

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. To advance equity in clinical research, the U.S. Clarify launched its real-world evidence on health disparities in 2021.

article thumbnail

Readjusting the Life Sciences Industry’s Approach to Improving Adherence

PM360

“The biologic patient journey is particularly fraught—patients are often unprepared and/or under-supported to navigate the specialty pharmacy process, prior authorization, financial burden, novel methods of drug administration, and consistent monitoring such as labs or check-ups,” Forster-Broten says. “As Eli Phillips, Jr.,

article thumbnail

MedWand Solutions Receives FDA 510k Clearance

Legacy MEDSearch

Food and Drug Administration (FDA) has granted 510(k) clearance to the MedWand,” shared MedWand CEO and Co-Founder, Robert Rose. “As MedWand Remote Clinic – Designed for remote / regional clinics, transport, and industrial application. To request a demo today visit www.medwand.com. “I About MedWand Solutions, Inc.

FDA 52
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Pharma 122